Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 24.3B | 23.6B | 23.4B | 23.2B |
Cost of revenue | 17.7B | 17.6B | 17.5B | 17.0B |
Gross profit | 6.7B | 6.0B | 5.9B | 6.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 2.9B | 2.7B | 2.1B | 2.8B |
Non operating interest income | ||||
Income | 2M | 8M | 7M | 3M |
Expense | 32M | 33M | 11M | 28M |
Other income expense | — | — | — | — |
Pretax income | 3.3B | 2.2B | 2.5B | 3.5B |
Tax provision | 923M | 944M | 826M | 1.1B |
Net income | 2.4B | 1.2B | 1.6B | 2.4B |
Basic EPS | — | — | — | 94.5 |
Diluted EPS | — | — | — | 94.5 |
Basic average shares | — | — | — | 25.4M |
Diluted average shares | — | — | — | 25.4M |
EBITDA | 3.8B | 2.8B | 2.6B | 3.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | 3M | 6M | 2M | 1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |